Analyst Recommendations

BMO Capital analyst issues MARKET PERFORM recommendation for DSGX on March 12, 2026 01:11PM ET. The previous analyst recommendation was Market Perform.DSGX was trading at $74.4653 at issue...

March 12, 2026   DSGX -0.95%

Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for UTHR on March 12, 2026 01:11PM ET. The previous analyst recommendation was Overweight.UTHR was trading at $536 at issue of the...

March 12, 2026   UTHR -3.53%

Benchmark analyst issues BUY recommendation for TATT on March 12, 2026 12:34PM ET. The previous analyst recommendation was Buy.TATT was trading at $56.39 at issue of the analyst...

March 12, 2026   TATT 2.55%

Benchmark analyst issues BUY recommendation for EXOD on March 12, 2026 12:33PM ET. The previous analyst recommendation was Buy.EXOD was trading at $9.69 at issue of the analyst...

March 12, 2026   EXOD 1.85%

Piper Sandler analyst issues OVERWEIGHT recommendation for PLRX on March 12, 2026 01:20PM ET. The previous analyst recommendation was Overweight.PLRX was trading at $1.356 at issue of the...

March 12, 2026   PLRX 3.97%

Piper Sandler analyst issues OVERWEIGHT recommendation for NTSK on March 12, 2026 01:19PM ET. The previous analyst recommendation was Overweight.NTSK was trading at $9.07 at issue of the...

March 12, 2026   NTSK -1.06%

Piper Sandler analyst issues OVERWEIGHT recommendation for PEP on March 12, 2026 01:18PM ET. The previous analyst recommendation was Overweight.PEP was trading at $160.8606 at issue of the...

March 12, 2026   PEP -0.41%

William Blair analyst issues MARKET PERFORM recommendation for PATH on March 12, 2026 01:17PM ET. The previous analyst recommendation was Market Perform.PATH was trading at $11.7301 at issue...

March 12, 2026   PATH -0.99%

Bank of America Securities analyst issues UNDERPERFORM recommendation for PATH on March 12, 2026 01:14PM ET. The previous analyst recommendation was Underperform.PATH was trading at $11.765 at issue...

March 12, 2026   PATH -0.99%

Cowen & Co. analyst issues BUY recommendation for BTMD on March 12, 2026 01:29PM ET. The previous analyst recommendation was Buy.BTMD was trading at $1.655 at issue of...

March 12, 2026   BTMD 6.30%